Type 1 fimbriae (T1F)

Type 1 fimbriae are filamentous surface appendages found on uropathogenic Escherichia coli (UPEC) and other Enterobacteriaceae, serving as critical virulence factors in the establishment of urinary tract infections (UTIs) [1, 2]. These structures are assembled via the chaperone-usher pathway and are composed primarily of FimA subunits, with the mannose-binding adhesin protein FimH located at the distal tip [1, 7]. FimH mediates the initial attachment of UPEC to mannosylated glycoproteins, such as uroplakin Ia, on the surface of bladder epithelial cells [2, 10]. This interaction is characterized by a catch-bond mechanism, where mechanical shear force from urine flow induces a conformational change in FimH that increases its binding affinity, allowing the bacteria to remain anchored to the urothelium [1, 21]. Beyond simple adhesion, Type 1 fimbriae facilitate bacterial invasion into host cells and the formation of intracellular bacterial communities (IBCs), which are essential for the persistence and recurrence of infections [2, 18]. Due to their pivotal role in pathogenesis, Type 1 fimbriae and the FimH adhesin are major targets for anti-adhesive therapeutic strategies, including small-molecule mannosides like Sibofimloc and vaccines designed to prevent bacterial colonization without inducing antibiotic resistance [5, 10, 17].

Other names

Type 1 piliFimH adhesinMannose-sensitive fimbriaeFim fimbriaeType 1 fimbrial adhesin

Anti-adhesive; competitive inhibition of the FimH lectin domain to prevent bacterial attachment to mannosylated host cell receptors.